Emergence of secondary acute lymphoblastic leukemia of Burkitt type after treatment of rhabdomyosarcoma.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000473:pathology*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007223:Infant; D016609:Neoplasms, Second Primary / Q000473:pathology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000188:drug therapy; D012208:Rhabdomyosarcoma / Q000175:diagnosis* / Q000628:therapy; D018570:Risk Assessment; D013899:Thoracic Neoplasms / Q000175:diagnosis* / Q000628:therapy; D013908:Thoracotomy / Q000379:methods